menu
    • menu

    Find Pimozide manufacturers, exporters & distributors on PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    9

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    3

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    0

    KDMF

    KDMF

    2

    NDC API

    NDC API

    0

    VMF

    NDC API

    2

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 7,858

    MARKET PLACE

    2

    API

    0

    FDF

    4INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    13

    FDF Dossiers

    FDF Dossiers

    4

    FDA Orange Book

    FDA (Orange Book)

    1

    Europe

    Europe

    4

    Canada

    Canada

    0

    Australia

    Australia

    2

    South Africa

    South Africa

    2

    Listed Dossiers

    Listed Dossiers

    1DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    3

    EDQM

    1

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    2

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    1,501,339

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    70 RELATED EXCIPIENT COMPANIES

    118EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 2062-78-4, Orap, Opiran, Pimozidum, Mcn-jr-6238, Pimozidum [inn-latin]
    Molecular Formula
    C28H29F2N3O
    Molecular Weight
    461.5  g/mol
    InChI Key
    YVUQSNJEYSNKRX-UHFFFAOYSA-N
    FDA UNII
    1HIZ4DL86F
    Pimozide
    A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)
    Pimozide is a Typical Antipsychotic.
    1 2D Structure

    Pimozide

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
    2.1.2 InChI
    InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)
    2.1.3 InChI Key
    YVUQSNJEYSNKRX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
    2.2 Other Identifiers
    2.2.1 UNII
    1HIZ4DL86F
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Antalon

    2. Orap

    3. Orap Forte

    4. R-6238

    5. R6238

    2.3.2 Depositor-Supplied Synonyms

    1. 2062-78-4

    2. Orap

    3. Opiran

    4. Pimozidum

    5. Mcn-jr-6238

    6. Pimozidum [inn-latin]

    7. R-6238

    8. R 6238

    9. R6238

    10. Nsc 170984

    11. Mcn-jr 6238

    12. 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1h-benzimidazol-2-one

    13. 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2h-benzimidazol-2-one

    14. 2h-benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-

    15. Nsc-170984

    16. 1-(1-(4,4-bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone

    17. 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone

    18. 1hiz4dl86f

    19. Chembl1423

    20. 1-(4,4-bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine

    21. Mls000028410

    22. Mls002702058

    23. Chebi:8212

    24. Nsc170984

    25. 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2h-benzimidazol-2-one

    26. 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1h-1,3-benzodiazol-2-one

    27. 2h-benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-

    28. Pimozida

    29. Ncgc00015802-08

    30. Ncgc00015802-18

    31. Primozida

    32. Smr000058385

    33. Cas-2062-78-4

    34. R 623

    35. R-623

    36. Dsstox_cid_3474

    37. 1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1h-benzo[d]imidazol-2(3h)-one

    38. Dsstox_rid_77042

    39. Dsstox_gsid_23474

    40. Primozida [inn-spanish]

    41. Primozide

    42. Pimozida [inn-spanish]

    43. 1-[4,4-bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine

    44. Ccris 9172

    45. Orap (tn)

    46. Sr-01000075392

    47. Einecs 218-171-7

    48. Unii-1hiz4dl86f

    49. Brn 0729089

    50. 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one

    51. Prestwick_395

    52. Mfcd00055081

    53. Pimozide [usan:usp:inn:ban:jan]

    54. Spectrum_000445

    55. Tocris-0937

    56. Pimozide [usan]

    57. Pimozide [inn]

    58. Pimozide [jan]

    59. Pimozide [mi]

    60. Pimozide [vandf]

    61. Opera_id_1580

    62. Prestwick0_000308

    63. Prestwick1_000308

    64. Prestwick2_000308

    65. Prestwick3_000308

    66. Spectrum2_001026

    67. Spectrum3_001451

    68. Spectrum4_000420

    69. Spectrum5_001308

    70. Lopac-p-1793

    71. Pimozide [mart.]

    72. Gtpl90

    73. Pimozide [usp-rs]

    74. Pimozide [who-dd]

    75. Ncimech_000356

    76. P 1793

    77. Lopac0_000946

    78. Schembl41584

    79. Bspbio_000276

    80. Bspbio_001439

    81. Bspbio_002941

    82. Kbiogr_000720

    83. Kbioss_000925

    84. 5-24-02-00367 (beilstein Handbook Reference)

    85. Mls001077311

    86. Bidd:gt0435

    87. Divk1c_000386

    88. Methyl-(2-m-tolylethyl)amine

    89. Spectrum1501134

    90. Pimozide (jp17/usp/inn)

    91. Spbio_001211

    92. Spbio_002495

    93. Pimozide [orange Book]

    94. Bpbio1_000304

    95. Schembl7519553

    96. Pimozide [ep Monograph]

    97. Dtxsid8023474

    98. Pimozide [usp Monograph]

    99. Bcbcmap01_000043

    100. Hms501d08

    101. Kbio1_000386

    102. Kbio2_000925

    103. Kbio2_003493

    104. Kbio2_006061

    105. Kbio3_002441

    106. Ninds_000386

    107. Hms1568n18

    108. Hms1791h21

    109. Hms1921h19

    110. Hms1989h21

    111. Hms2089c11

    112. Hms2092f09

    113. Hms2095n18

    114. Hms2231p23

    115. Hms3262n14

    116. Hms3267e19

    117. Hms3370n13

    118. Hms3402h21

    119. Hms3411j16

    120. Hms3675j16

    121. Hms3712n18

    122. Pharmakon1600-01501134

    123. Zinc4175630

    124. Tox21_110224

    125. Tox21_301586

    126. Tox21_500946

    127. Bdbm50334150

    128. Ccg-35918

    129. Ccg-36461

    130. Ccg-39728

    131. Nsc757854

    132. S4358

    133. 2-benzimidazolinone, 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-

    134. 3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1h-benzimidazol-2-one

    135. Akos024458706

    136. Tox21_110224_1

    137. Db01100

    138. Lp00946

    139. Nsc-757854

    140. Sdccgsbi-0050920.p004

    141. Idi1_000386

    142. Smp1_000241

    143. Ncgc00015802-01

    144. Ncgc00015802-02

    145. Ncgc00015802-03

    146. Ncgc00015802-04

    147. Ncgc00015802-05

    148. Ncgc00015802-06

    149. Ncgc00015802-07

    150. Ncgc00015802-09

    151. Ncgc00015802-10

    152. Ncgc00015802-11

    153. Ncgc00015802-12

    154. Ncgc00015802-13

    155. Ncgc00015802-14

    156. Ncgc00015802-15

    157. Ncgc00015802-16

    158. Ncgc00015802-26

    159. Ncgc00015802-29

    160. Ncgc00016601-01

    161. Ncgc00022282-03

    162. Ncgc00024888-01

    163. Ncgc00024888-02

    164. Ncgc00024888-03

    165. Ncgc00024888-04

    166. Ncgc00024888-05

    167. Ncgc00024888-06

    168. Ncgc00024888-07

    169. Ncgc00255294-01

    170. Ncgc00261631-01

    171. As-13916

    172. Hy-12987

    173. Sbi-0050920.p003

    174. Ab00052215

    175. Cs-0012921

    176. Eu-0100946

    177. Ft-0673903

    178. Sw196639-3

    179. C07566

    180. D00560

    181. F70142

    182. Ab00052215-06

    183. Ab00052215_07

    184. Ab00052215_08

    185. 062p784

    186. L000494

    187. Q144085

    188. Wln: T56 Bmvnj D- Dt6ntj A3yr Df&r Df

    189. J-013477

    190. Sr-01000075392-1

    191. Sr-01000075392-3

    192. Sr-01000075392-4

    193. Sr-01000075392-6

    194. Brd-k01292756-001-06-0

    195. Brd-k01292756-001-13-6

    196. Pimozide, European Pharmacopoeia (ep) Reference Standard

    197. Z241910386

    198. 2-benzimidazolinone,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-

    199. N-benzyl-n-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)benzenamine

    200. Pimozide, United States Pharmacopeia (usp) Reference Standard

    201. 1-[1-[4,4-bis(p-flurophenyl)butyl]-4-piperidyl]-2-benzimidazolinone

    202. 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone

    203. 1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazol-2-one

    204. 1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one

    205. 2h-benzimidazol-2-one,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-

    206. 1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one(pimozide)

    207. 2h-benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro

    208. Pimozide (1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2h-benzimidaol-2-one)

    209. Pimozide1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one

    2.4 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 461.5 g/mol
    Molecular Formula C28H29F2N3O
    XLogP36.3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count7
    Exact Mass461.22786888 g/mol
    Monoisotopic Mass461.22786888 g/mol
    Topological Polar Surface Area35.6 Ų
    Heavy Atom Count34
    Formal Charge0
    Complexity632
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameOrap
    PubMed HealthPimozide (By mouth)
    Drug ClassesAntipsychotic
    Drug LabelORAP (pimozide) is an orally active antipsychotic agent of the diphenyl-butylpiperidine series. The structural formula of pimozide, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazole-2-one is:The solubility of pimozide...
    Active IngredientPimozide
    Dosage FormTablet
    RouteOral
    Strength1mg; 2mg
    Market StatusPrescription
    CompanyTeva

    2 of 2  
    Drug NameOrap
    PubMed HealthPimozide (By mouth)
    Drug ClassesAntipsychotic
    Drug LabelORAP (pimozide) is an orally active antipsychotic agent of the diphenyl-butylpiperidine series. The structural formula of pimozide, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazole-2-one is:The solubility of pimozide...
    Active IngredientPimozide
    Dosage FormTablet
    RouteOral
    Strength1mg; 2mg
    Market StatusPrescription
    CompanyTeva

    4.2 Drug Indication

    Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Pimozide is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system. However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide's therapeutic and untoward effects. In addition, pimozide, in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized. Pimozide also has less potential for inducing sedation and hypotension as it has more specific dopamine receptor blocking activity than other neuroleptic agents (and is therefore a suitable alternative to haloperidol).

    5.2 MeSH Pharmacological Classification

    Dopamine Antagonists

    Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)

    Antipsychotic Agents

    Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

    Anti-Dyskinesia Agents

    Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. (See all compounds classified as Anti-Dyskinesia Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    PIMOZIDE
    5.3.2 FDA UNII
    1HIZ4DL86F
    5.3.3 Pharmacological Classes
    Typical Antipsychotic [EPC]
    5.4 ATC Code

    N05AG02

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    N - Nervous system

    N05 - Psycholeptics

    N05A - Antipsychotics

    N05AG - Diphenylbutylpiperidine derivatives

    N05AG02 - Pimozide

    5.5 Absorption, Distribution and Excretion

    Absorption

    Greater than 50% absorption after oral administration. Serum peak appears 6-8 hours post ingestion.

    5.6 Metabolism/Metabolites

    Notable first-pass metabolism in the liver, primarily by N-dealkylation via the cytochrome P450 isoenzymes CYP3A and CYP1A2 (and possibly CYP2D6). The activity of the two major metabolites has not been determined.

    Pimozide has known human metabolites that include 1,3- dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one (DHPBI).

    S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

    5.7 Biological Half-Life

    29 ± 10 hours (single-dose study of healthy volunteers).

    5.8 Mechanism of Action

    The ability of pimozide to suppress motor and phonic tics in Tourette's Disorder is thought to be primarily a function of its dopaminergic blocking activity. Pimozide binds and inhibits the dopamine D2 receptor in the CNS.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677090600,"product":"PIMOZIDE USP","address":"503, ORCHID PLAZA,NATAKWALA LANE,, OFF. S V ROAD, NEAR DATTAPADA SUBWA","city":"BORIVALI - WEST,MAHARASHTRA","supplier":"AADIVIGHNESH CHEM","supplierCountry":"INDIA","foreign_port":"ZURICH","customer":"S A G","customerCountry":"SWITZERLAND","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"16000","totalValueFC":"1574","currency":"USD","unitRateINR":1300000,"date":"23-Feb-2023","totalValueINR":"130000","totalValueInUsd":"1574","indian_port":"BOMBAY AIR","hs_no":"29333990","bill_no":"7994927","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"503, ORCHID PLAZA,NATAKWALA LANE,, OFF. S V ROAD, NEAR DATTAPADA SUBWA, BORIVALI - WEST,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683052200,"product":"ACTIVE PHARMACEUTICAL INGREDIENT OTHERREF NO 2301260090 DT 28 04 2023 PIMOZIDE USP","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"BANGKOK","customer":"TO THE ORDER","customerCountry":"THAILAND","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7722","totalValueFC":"7607.8","currency":"USD","unitRateINR":626000,"date":"03-May-2023","totalValueINR":"626000","totalValueInUsd":"7607.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"THAILAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683052200,"product":"ACTIVE PHARMACEUTICAL INGREDIENT REF NO 2301260094 DT 28 04 2023 PIMOZIDE USP","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"TO THE ORDER","customerCountry":"UNITED STATES","quantity":"0.16","actualQuantity":"0.16","unit":"KGS","unitRateFc":"13750","totalValueFC":"2175.4","currency":"USD","unitRateINR":1118750,"date":"03-May-2023","totalValueINR":"179000","totalValueInUsd":"2175.4","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690482600,"product":"PIMOZIDE.PH.EUR (ACTIVE PHARMACEUTICAL","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"'TO THE ORDER","customerCountry":"TAIWAN","quantity":"1.20","actualQuantity":"1.2","unit":"KGS","unitRateFc":"11000","totalValueFC":"13006.5","currency":"USD","unitRateINR":890833.125,"date":"28-Jul-2023","totalValueINR":"1068999.75","totalValueInUsd":"13006.5","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""}]
    23-Feb-2023
    28-Jul-2023
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - 1MG **Federal Register...DOSAGE - TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 17473

    read-more

    DOSAGE - TABLET;ORAL - 2MG **Federal Register...DOSAGE - TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 17473

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Pimozide Manufacturers

    A Pimozide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pimozide, including repackagers and relabelers. The FDA regulates Pimozide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pimozide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Pimozide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Pimozide Suppliers

    A Pimozide supplier is an individual or a company that provides Pimozide active pharmaceutical ingredient (API) or Pimozide finished formulations upon request. The Pimozide suppliers may include Pimozide API manufacturers, exporters, distributors and traders.

    click here to find a list of Pimozide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Pimozide USDMF

    A Pimozide DMF (Drug Master File) is a document detailing the whole manufacturing process of Pimozide active pharmaceutical ingredient (API) in detail. Different forms of Pimozide DMFs exist exist since differing nations have different regulations, such as Pimozide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Pimozide DMF submitted to regulatory agencies in the US is known as a USDMF. Pimozide USDMF includes data on Pimozide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pimozide USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Pimozide suppliers with USDMF on PharmaCompass.

    Pimozide CEP

    A Pimozide CEP of the European Pharmacopoeia monograph is often referred to as a Pimozide Certificate of Suitability (COS). The purpose of a Pimozide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pimozide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pimozide to their clients by showing that a Pimozide CEP has been issued for it. The manufacturer submits a Pimozide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pimozide CEP holder for the record. Additionally, the data presented in the Pimozide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pimozide DMF.

    A Pimozide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pimozide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of Pimozide suppliers with CEP (COS) on PharmaCompass.

    Pimozide WC

    A Pimozide written confirmation (Pimozide WC) is an official document issued by a regulatory agency to a Pimozide manufacturer, verifying that the manufacturing facility of a Pimozide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pimozide APIs or Pimozide finished pharmaceutical products to another nation, regulatory agencies frequently require a Pimozide WC (written confirmation) as part of the regulatory process.

    click here to find a list of Pimozide suppliers with Written Confirmation (WC) on PharmaCompass.

    Pimozide NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pimozide as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Pimozide API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Pimozide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Pimozide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pimozide NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Pimozide suppliers with NDC on PharmaCompass.

    Pimozide GMP

    Pimozide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Pimozide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pimozide GMP manufacturer or Pimozide GMP API supplier for your needs.

    Pimozide CoA

    A Pimozide CoA (Certificate of Analysis) is a formal document that attests to Pimozide's compliance with Pimozide specifications and serves as a tool for batch-level quality control.

    Pimozide CoA mostly includes findings from lab analyses of a specific batch. For each Pimozide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Pimozide may be tested according to a variety of international standards, such as European Pharmacopoeia (Pimozide EP), Pimozide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pimozide USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search